Picras-3-en-21-oic acid, 15-(acetyloxy)-13,20-epoxy-3-(β-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-, methyl ester, (11β,12α,15β)- - Names and Identifiers
Picras-3-en-21-oic acid, 15-(acetyloxy)-13,20-epoxy-3-(β-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-, methyl ester, (11β,12α,15β)- - Physico-chemical Properties
Molecular Formula | C29H38O16
|
Molar Mass | 642.61 |
Density | 1.61±0.1 g/cm3(Predicted) |
Boling Point | 881.8±65.0 °C(Predicted) |
Appearance | Powder |
pKa | 12.53±0.70(Predicted) |
Storage Condition | 2-8℃ |
Picras-3-en-21-oic acid, 15-(acetyloxy)-13,20-epoxy-3-(β-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-, methyl ester, (11β,12α,15β)- - Introduction
Yadanzioside I (Yadanzioside I) is a component isolated from Brucea javanica. It belongs to terpenoids, chemical formula is C32H36O13, with a complex structure. Yadanzioside I is a colorless crystalline solid with low solubility in water.
Yadanzioside I has a wide range of applications in the field of pharmacy. It was found to have some anti-tumor activity, inhibiting the growth and spread of tumor cells. Therefore, it has potential application value in cancer treatment. In addition, Yadanzioside I is also studied for the treatment of cardiovascular diseases, immune regulation and anti-inflammatory.
The method of preparing Yadanzioside I is mainly obtained by extraction and purification from Brucea javanica. The general preparation method is to grind Brucea javanica, add appropriate amount of solvent (such as alcohol, ether, etc.), after extraction, extract, concentration and crystallization steps, and finally get the pure product of Yadanzioside I.
Regarding the safety information of Yadanzioside I, there is no large-scale toxicological and safety evaluation data. Therefore, you should pay attention to the appropriate amount of use, and follow the advice of doctors or professionals. In addition, for pregnant women, lactating women and children, Yadanzioside I should be avoided to avoid adverse reactions. In case of any discomfort or allergic reaction during use, stop use immediately and seek medical advice.
Last Update:2024-04-10 22:29:15